Harvard Bioscience Inc (HBIO)
3.695
-0.02
(-0.67%)
USD |
NASDAQ |
Apr 24, 15:53
Harvard Bioscience Market Cap: 160.36M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 161.45M |
| April 22, 2024 | 160.58M |
| April 19, 2024 | 160.58M |
| April 18, 2024 | 172.30M |
| April 17, 2024 | 177.50M |
| April 16, 2024 | 181.41M |
| April 15, 2024 | 192.69M |
| April 12, 2024 | 184.01M |
| April 11, 2024 | 188.57M |
| April 10, 2024 | 184.88M |
| April 09, 2024 | 200.94M |
| April 08, 2024 | 187.05M |
| April 05, 2024 | 196.16M |
| April 04, 2024 | 193.99M |
| April 03, 2024 | 182.28M |
| April 02, 2024 | 180.98M |
| April 01, 2024 | 184.88M |
| March 28, 2024 | 184.01M |
| March 27, 2024 | 182.28M |
| March 26, 2024 | 174.47M |
| March 25, 2024 | 179.24M |
| March 22, 2024 | 180.98M |
| March 21, 2024 | 189.22M |
| March 20, 2024 | 190.96M |
| March 19, 2024 | 190.96M |
| Date | Value |
|---|---|
| March 18, 2024 | 180.11M |
| March 15, 2024 | 175.77M |
| March 14, 2024 | 186.18M |
| March 13, 2024 | 190.52M |
| March 12, 2024 | 185.32M |
| March 11, 2024 | 189.22M |
| March 08, 2024 | 191.82M |
| March 07, 2024 | 195.73M |
| March 06, 2024 | 178.37M |
| March 05, 2024 | 181.84M |
| March 04, 2024 | 189.65M |
| March 01, 2024 | 188.79M |
| February 29, 2024 | 187.90M |
| February 28, 2024 | 190.07M |
| February 27, 2024 | 191.80M |
| February 26, 2024 | 189.63M |
| February 23, 2024 | 191.37M |
| February 22, 2024 | 190.94M |
| February 21, 2024 | 192.67M |
| February 20, 2024 | 187.90M |
| February 16, 2024 | 196.14M |
| February 15, 2024 | 210.90M |
| February 14, 2024 | 203.52M |
| February 13, 2024 | 189.20M |
| February 12, 2024 | 208.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
54.45M
Minimum
Mar 19 2020
345.26M
Maximum
Aug 12 2021
175.08M
Average
160.08M
Median
Market Cap Benchmarks
| Bruker Corp | 11.36B |
| Azenta Inc | 2.905B |
| Bionano Genomics Inc | 46.57M |
| Akoya Biosciences Inc | 187.23M |
| Singular Genomics Systems Inc | 29.12M |
Market Cap Related Metrics
| PS Ratio | 1.403 |
| Price to Book Value | 2.194 |
| Price to Free Cash Flow | 13.44 |
| Price | 3.695 |
| Earnings Yield | -2.17% |
| Operating PE Ratio | 83.14 |